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Laurent Blanchoin graduated in 
cell and molecular biology from the 
University of Paris VI in 1996 after 
working with Marie-France Carlier. 
He then pursued his postdoctoral 
work with Tom Pollard, first at Johns 
Hopkins Medical School in Baltimore 
and then at the Salk Institute for 
Biological Studies in La Jolla. In 2001, 
he was awarded a young investigator 
grant to start his own group at the 
Cell & Plant Physiology Laboratory 
in Grenoble, where he began 
investigating molecular mechanisms 
controlling actin cytoskeleton 
dynamics using a combination 
of biochemical, biophysical and 
theoretical approaches. In 2009, 
together with Manuel Théry, he 
created the Cytomorpho Lab in the 
Nanobiology Campus in Grenoble, 
where he is trying to connect in vitro 
biophysical approaches with cell 
biology to establish the rules directing 
cytoskeleton organization during 
morphogenesis. An important part 
of the effort in their lab is to develop 
original technological tools that can 
be used at the molecular and cellular 
levels, thus helping to bridge these 
different levels of complexity. 
How or when did you decide to move 
to science? I never had a big career 
plan. After my baccalaureate, I went 
to university because I did not know 
exactly what to do and in France this 
is a classical choice. My first three 
years at university, in fact, I was more 
interested in sports (running) than 
science. Maybe because of the way 
biology was taught at the University 
in Toulouse, science was not so 
appealing. What actually got me 
interested in science was working in 
a lab. I did a 6 month rotation in the 
early 90s in a small startup company 
and every day I was exposed to a 
stimulating intellectual challenge, 
from the design of new experiments 
to the use of new technological tools. 
Working in a lab felt rapidly like home 
to me. But after my master’s degree, 
I had to stop for a year to do my 
military service. Coming back from 
this unique experiment, I was really 
motivated to start a PhD, but it was 
very difficult to find a position after 
Q & Athis break. I was really lucky because 
the Carlier lab in Gif-sur-Yvette was 
looking for a PhD student with my 
profile to work on the biophysics of 
the acto-myosin system. At the time, I 
did not know that this choice to work 
on the cytoskeleton would have such 
a huge impact on my carrier. Even 
after 20 years, I am still fascinated 
by the challenge of understanding 
cytoskeleton organization.
After your PhD how did you decide 
where to go for your postdoc?  
At the end of my PhD, the Carlier 
lab started to work on actin-based 
motility using Listeria monocytogenes 
as a model system. I was then and 
am still now really excited by the 
challenge of understanding how the 
cytoskeleton can generate a force. 
You also have to realize that, even 
if I am not that old, we did not have 
access to the Internet at the time. 
I had my first e-mail account at the 
end of my PhD. So I was using the 
current content to follow the scientific 
developments on this topic. And 
I really enjoyed the quantitative 
cell biology from the Pollard lab. 
Specifically, his classic paper 
from 1986 where he used electron 
microscopy to determine the rate 
constant of actin at the end of the 
filament. In addition to how elegantly the experiment was designed, I was 
very impressed because Tom is the 
only author on the paper. Once again, 
I was lucky that Tom had a position 
available in his lab for me just after 
my PhD, so I moved to Johns Hopkins 
Medical School in Baltimore and 
afterwards to California at the Salk 
Institute when he became the Salk 
president. It was an amazing time, 
both at the scientific level because 
during this period (5 years) the entire 
actin field was really creative and 
some major discoveries — including 
the mechanism of actin nucleation 
and branched actin network formation 
together with the reconstitution of 
actin-based motility — were made, 
but also at the personal level. In 
addition to working with Tom, I had 
the chance to interact with amazing 
young scientists in the lab who are 
now well-established professors. 
Any advice for young PhD students? 
I think the first question that they 
should ask for themselves is: how 
much effort am I ready to put into 
science? I think for most of us 
science is not a job but a passion. 
So we are ready to accept a lot of 
frustration to achieve this passion, 
including failed experiments, grant 
success rates below 10%, rejected 
papers, unjustified criticisms 
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 at conferences or meetings by 
colleagues… But the pay-off is every 
day when you come to the lab, you 
feel that a new challenge is in front 
of you and this is very exciting. In 
some ways, I find in science what 
I experienced as a competitive 
runner. You train very hard, which is 
sometimes painful, but the challenge 
to beat your best time is what takes 
all the pain away.
How has your job changed since 
you started? Actually, when I was 
a student or a postdoc I did not 
realize how lucky I was to be able to 
do science without worrying about 
anything else. Now as a PI, this is 
the opposite; an important part of 
my job is to take care of everything 
in addition to the science. I often 
compare my job to the head of a small 
company where I need to make sure 
the money is OK, the equipment is 
running and the people in the lab are 
happy on a day-to-day basis. This part
of the job nobody really teaches you. 
And with the economic crisis, running 
a lab is not easy because the money 
is tight. But I should admit, I really 
enjoy interacting with the people in my
group and seeing them growing and 
moving away is really rewarding, but it 
is also sad when they leave. 
I also changed my way of doing 
science. Early in my career as PI, I 
tried to limit the risk by addressing 
a question limited to the biophysics 
of the actin system. Then, our work 
became more interdisciplinary 
with important contributions from 
computational biology or modeling. 
Now, we are expanding our lab 
towards systems biology where we 
use a combination of technological 
tools that we developed in the lab — 
imaging-based assays in vitro and in 
living cells, as well as biochemistry 
and biophysics together with theory 
and modeling.
If you could do it over, would you 
pursue the same research career? 
Yes, I would choose the same career 
with the same scientific questions 
but I would try early on to expand my 
knowledge in physics, mathematics 
and chemistry. Our field is truly 
interdisciplinary and I spend more 
and more time interacting with our 
collaborators using mathematical and 
biophysical modeling that provide 
the tools necessary to formalize 
the concepts developed in the lab. Having a strong background in these 
disciplines would definitely help 
me to enjoy interacting with these 
colleagues even more.
What are you doing outside science? 
I have a family with two kids, 5 and 
10 years old, and my wife is also 
a scientist. But we try — and it is 
not always easy — to have time 
outside science for the kids. As a big 
commitment, we decided to travel 
together as a family for four weeks 
every year. Last year we went to 
Indonesia, this year we are going 
to Vietnam and Cambodia. This is a 
fantastic time, because all the family 
is discovering a new way to live and 
every day for four weeks is a new 
adventure. When we come back from 
such a trip, in addition to having seen 
some fantastic place, we realize how 
easy life is in France. 
How do you see the future of 
your field? There is no doubt that 
technological development is an 
important aspect of what drives the 
cytoskeleton field in particular, and 
cell biology in general. For example, 
until 2001, it was almost impossible 
to follow a single actin filament 
growing in vitro. And the first time I 
saw a direct visualization of an actin 
filament under a TIRF microscope, I 
knew that the actin field would not be 
the same. And in the past 10 years 
the new discoveries made based on 
the use of this technique to study 
cytoskeleton dynamics have been 
unmatched. In addition to improving 
imaging technology and analysis, 
labs are developing microfluidics, 
microfabrication, surface patterning, 
and force measurement tools that 
allow us to ask new questions about 
the physics of the cytoskeleton and 
its relevance for its organization and 
cellular function. This is true not only 
at the molecular level in vitro, but also 
at the cellular level where the field of 
mechanobiology really benefits from 
new technological tools. 
We see also the appearance of 
optogenetics, which allows us to 
locally and rapidly manipulate the 
cell, limiting the possibility for the 
system to adapt to a perturbation. 
Proteins in general, and molecular 
motors in particular, can also be 
manipulated by light, allowing them 
to change step size or directionality. 
By doing so, we can really start to 
dissect how molecular properties correlate with a cellular response. I 
truly believe that this is one of the 
major challenges in biology, we 
have a good understanding of how 
molecules work, we know their cellular 
localization, but it is very difficult to 
translate a molecular mechanism to 
a cellular response and even more 
difficult if we consider the multicellar 
or tissue level.
Where do you see room for 
improvement in science? I think, 
as scientists, we should realize that 
our duty is to share our discoveries 
as quickly as possible. In most 
cases, because we are afraid of 
competition or not to be the first 
to publish a result, we hide our 
findings until the last moment. This 
tactic is obvious at meetings where 
the amount of unpublished data 
presented is decreasing. I remember 
a meeting last year where a postdoc 
showed a result on a poster and 
would not tell anybody how he did 
his experiment. I understand the 
importance of the publication for 
a career but to move the science 
faster it is really a limitation. I am not 
against competition — I think it is 
good because you are often better 
when you compete with somebody 
for a goal — but we should be able 
to communicate better, at least at 
meetings or conferences. In that 
sense, Gordon Conferences are 
in general very good because it 
is mandatory if you give a talk to 
present unpublished results and I 
truly believe that should be a general 
rule instead of an exception. 
This is also why I see joint grants 
between different PIs as a very good 
way to have experts working together. 
I had the chance in 2009–2010 to 
have my friend Enrique De La Cruz, 
professor at Yale, come for a year’s 
sabbatical in my lab. It was just 
fantastic to have him around and 
we exchanged so many ideas that 
we rapidly made some important 
breakthroughs. In that sense, having 
a joint lab with Manuel Théry also 
helps a lot. I do not think I want to go 
back to being the sole PI of my group 
because we learn so much from each 
other that the science is not only more 
fun but definitely more efficient. 
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